Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy-Reference-Cited by-同舟云学术

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

Published:2016 Issue: Volume:3 Page:16021
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Dold Catherine,Rodriguez Urbiola Carles,Wollmann Guido,Egerer Lisa,Muik Alexander,Bellmann Lydia,Fiegl Heidelinde,Marth Christian,Kimpel Janine,von Laer Dorothee

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference48 articles.

1. Breast and cervical cancer in 187 countries between 1980 and 2010;Ferlay;Lancet,2012

2. Beyond chemotherapy: targeted therapies in ovarian cancer;Yap;Nat Rev Cancer,2009

3. The emerging role of viruses in the treatment of solid tumours;Bourke;Cancer Treat Rev,2011

4. Vesicular stomatitis virus: re-inventing the bullet;Lichty;Trends Mol Med,2004

5. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications;Tober;J Virol,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system;Antiviral Research;2024-11

2. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11

3. Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer;Molecular Therapy: Oncology;2024-09

4. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects;Signal Transduction and Targeted Therapy;2024-05-03

5. Microbial-Based Therapies in Cancer Treatment Under the One Health Initiative;Interdisciplinary Cancer Research;2024